Heterogeneous transforming growth factor (TGF)-β unresponsiveness and loss of TGF-β receptor type II expression caused by histone deacetylation in lung cancer cell lines

被引:0
|
作者
Osada, H [1 ]
Tatematsu, Y [1 ]
Masuda, A [1 ]
Saito, T [1 ]
Sugiyama, M [1 ]
Yanagisawa, K [1 ]
Takahashi, T [1 ]
机构
[1] Aichi Canc Ctr, Res Inst, Div Mol Oncol, Chikusa Ku, Nagoya, Aichi 4648681, Japan
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Transforming growth factor (TGF)-beta strongly inhibits epithelial cell proliferation. Alterations of TGF-beta signaling are thought to play a role in tumorigenesis. We show in the present study that most lung cancer cell lines have lost the growth-inhibitory response to TGF-beta signal, and that those with TGF-beta unresponsiveness can be divided into two major groups, TGF-beta type II receptor (TGF beta RII)(+)/Smad7(+) and TGF beta RII(-)/Smad7(-), suggesting the heterogeneous mechanisms underlying the TGF-beta responsiveness. The mechanism of the loss of TGF beta RII expression of the latter group was further studied, identifying aberrant DNA methylation of the promoter region in a limited fraction of cell lines. Interestingly, we found that the alteration of chromatin structure because of histone deacetylation may also be involved, showing a good correlation with loss of TGF beta RII expression. This notion was supported by the findings of a restriction enzyme accessibility assay, of a chromatin immunoprecipitation assay with anti-acetyl historic antibodies, and of an in vivo induction of TGF beta RII expression by histone deacetylase inhibitors including trichostatin A (TSA) and sodium butyrate. In vitro induction of TGF beta RII promoter reporter activity by TSA was also detected and found to require the CCAAT box within the -127/-75 region. A positive regulatory mechanism for TGF beta RII expression in a TGF-beta -expressing cell line was also investigated, and a TPA-responsive element (TRE)-like motif, TRE2, was detected in addition to the previously reported TRE-like motif Y element in the positive regulatory region. Alterations in two discrete proteins interacting with these two TRE-like motifs were also suspected of being involved in the loss of TGF beta RII expression. This is the first study to demonstrate that, in addition to the TSA-responsive region and TRE2 motif in the TGF beta RII promoter, the alteration of histone deacetylation may be involved in the loss of TGF beta RII expression in lung cancer cell lines.
引用
收藏
页码:8331 / 8339
页数:9
相关论文
共 50 条
  • [31] Selective Deletion of the Natural Killer Cell Type II Transforming Growth Factor-β (TGF-β) Receptor Impairs Murine Lung Development and Function
    Gainer, D.
    Coyle, K. M.
    Vivier, E.
    Domnik, N.
    Ormiston, M. L.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209
  • [32] Serum level of transforming growth factor-β1 (TGF-β1) and the expression of TGF-β receptor type II in peripheral blood mononuclear cells in patients with autoimmune hepatitis
    Sakaguchi, K
    Kitano, M
    Nishimura, M
    Senoh, T
    Ohta, T
    Terao, M
    Shinji, N
    Koide, N
    Tsuji, T
    HEPATO-GASTROENTEROLOGY, 2004, 51 (60) : 1780 - 1783
  • [33] Neonatal and Adult Dermal Fibroblasts Show Differences in Transforming Growth Factor (TGF-β) Secretion and TGF-β Type II Receptor Expression at Baseline and Under Constant Stretch Conditions
    Glass, C.
    Cullen, J.
    Roztoeil, E.
    Doan, C.
    Augustin, G.
    Illig, K.
    Singh, M.
    Gillespie, D.
    JOURNAL OF VASCULAR SURGERY, 2010, 51 (03) : 795 - 796
  • [34] Expression of transforming growth factor(TGF)-Beta 1 and TGF type II receptor in the renal parenchyme of diabetic and nephrectomized rats
    Sol, MY
    Lee, KS
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 : 891A - 891A
  • [35] The type II transforming growth factor (TGF)-β receptor-interacting protein TRIP-1 acts as a modulator of the TGF-β response
    Choy, L
    Derynck, R
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (47) : 31455 - 31462
  • [36] Chimeric extracellular domain of type II transforming growth factor (TGF)-β receptor fused to the Fc region of human immunoglobulin as a TGF-β antagonist
    Komesli, S
    Vivien, D
    Dutartre, P
    EUROPEAN JOURNAL OF BIOCHEMISTRY, 1998, 254 (03): : 505 - 513
  • [37] Type III transforming growth factor-β (TGF-β) receptor mediates apoptosis in renal cell carcinoma independent of the canonical TGF-β signaling pathway
    Margulis, Vitally
    Maity, Tapati
    Zhang, Xiu-Ying
    Cooper, Simon J.
    Copland, John A.
    Wood, Christopher G.
    CLINICAL CANCER RESEARCH, 2008, 14 (18) : 5722 - 5730
  • [38] Lack of correlation between growth inhibition by TGF-β and the percentage of cells expressing type II TGF-β receptor in human non-small cell lung carcinoma cell lines
    Löpez-González, JS
    Aguilar-Cázares, D
    Prado-García, H
    Nieto-Rodríguez, A
    Mandoki, JJ
    Avila-Moreno, F
    Rivera, RM
    Chavarría-Garcés, J
    LUNG CANCER, 2002, 38 (02) : 149 - 158
  • [39] Ontogeny of expression of transforming growth factor-β1 (TGF-β1), TGF-β3, and TGF-β receptors I and II in fetal rat fibroblasts and skin
    Hsu, M
    Peled, ZM
    Chin, GS
    Liu, W
    Longaker, MT
    PLASTIC AND RECONSTRUCTIVE SURGERY, 2001, 107 (07) : 1787 - 1794
  • [40] Inactivation of the transforming growth factor β type II receptor in human small cell lung cancer cell lines
    S Hougaard
    P Nørgaard
    N Abrahamsen
    H L Moses
    M Spang-Thomsen
    H Skovgaard Poulsen
    British Journal of Cancer, 1999, 79 : 1005 - 1011